NormandIcc Profile Banner
Pr Fabrice Bauer Profile
Pr Fabrice Bauer

@NormandIcc

Followers
55
Following
144
Media
12
Statuses
114

Advanced Heart Failure and Pulmonary Hypertension. Structural Heart Failure Disease. Cardiac Amylodosis

Rouen University Hospital
Joined October 2021
Don't wanna be here? Send us removal request.
@NormandIcc
Pr Fabrice Bauer
2 months
RT @ACCinTouch: “With an ever-growing population of #HeartFailure patients, it seems counterintuitive that fewer cardiology fellows are pur….
0
1
0
@NormandIcc
Pr Fabrice Bauer
4 months
RT @EJHFEiC: Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the #HFA….
0
24
0
@grok
Grok
3 days
Join millions who have switched to Grok.
151
284
2K
@NormandIcc
Pr Fabrice Bauer
4 months
RT @EJHFEiC: 🗞️ The use of #LVEF in the diagnosis and management of #heartfailure. A clinical consensus statement of the #HFA of @escardio,….
0
42
0
@NormandIcc
Pr Fabrice Bauer
5 months
RT @ACCinTouch: Limiting fluid intake may have no benefit for patients with #HeartFailure, according to findings from the FRESH-UP study pr….
0
32
0
@NormandIcc
Pr Fabrice Bauer
5 months
RT @ACCinTouch: If you missed the LBCT session this morning, catch up with #ACC25 and follow the meeting coverage here ➡️ .
Tweet card summary image
acc.org
This page features full coverage of the latest science from ACC.25, including trial summaries, news stories, journal scans, slides, videos and more.
0
7
0
@NormandIcc
Pr Fabrice Bauer
5 months
RT @hvanspall: In this RCT of 1766 patients with #cancer and history of #VTE, extended apixaban 2.5 mg bid was non-inferior (NIF margin 2.0….
0
14
0
@NormandIcc
Pr Fabrice Bauer
5 months
RT @ACCinTouch: ALIGN-AR: Among patients with aortic regurgitation undergoing #TAVR with the Trilogy valve, the rate of mortality at one ye….
0
8
0
@NormandIcc
Pr Fabrice Bauer
5 months
0
1
0
@NormandIcc
Pr Fabrice Bauer
5 months
RT @CircAHA: #ACC25 #CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation s….
0
55
0
@NormandIcc
Pr Fabrice Bauer
6 months
RT @CircAHA: A visionary in structural heart disease & interventional echocardiography, Dr. Rebecca T. Hahn has revolutionized valve imagin….
0
33
0
@NormandIcc
Pr Fabrice Bauer
7 months
RT @RyanTedfordMD: 🔥🔥First LBCT session of #THT2025 - @JavedButler1 shares 2 year outcome data from the ALT-FLOW single-arm EFS. Signific….
0
8
0
@NormandIcc
Pr Fabrice Bauer
9 months
RT @walinjom: Right Heart Catheterization:
Tweet media one
0
116
0
@NormandIcc
Pr Fabrice Bauer
1 year
Nice to see 3 of my students belonging to this so-important group.
@CharlesFauvel
Charles Fauvel
1 year
🇫🇷🫶🏻🤙🏼.
0
0
5
@NormandIcc
Pr Fabrice Bauer
2 years
RT @DrJMTartiere: Rapport de la cours des comptes sur la mise en place des #IPA en 2023.Sans surprise 2 freins majeurs 1️⃣opposition active….
0
6
0
@NormandIcc
Pr Fabrice Bauer
2 years
RT @EJHFEiC: Potential global impact of SGLT2-inhibitors. Prevent and postpone ~8 million worsening HF events and cardiovascular ☠️ over 3….
0
45
0
@NormandIcc
Pr Fabrice Bauer
2 years
RT @Discover_Echo: ECHO Confocal has arrived, learn more about how our latest microscope will bring high-resolution imaging to the lab.
0
50
0
@NormandIcc
Pr Fabrice Bauer
2 years
RT @ACCinTouch: Pulmonary vein stenosis can arise from several etiologies, including congenital, acquired & iatrogenic sources. PVS present….
0
58
0
@NormandIcc
Pr Fabrice Bauer
2 years
RT @HFA_President: I'm beyond excited to announce the Clinical Trials in HF Course. 3 Days. Learn how to:.▶️ how to design trials.▶️ how to….
0
32
0
@NormandIcc
Pr Fabrice Bauer
2 years
RT @FeliceGragnano: On May 26, the @US_FDA approved #sotagliflozin, the first dual SGLT-1/2 inhibitor for #HF treatment (regardless of EF).….
0
11
0
@NormandIcc
Pr Fabrice Bauer
2 years
RT @radcliffeCARDIO: During this new podcast episode, we hear how primary care is ideally positioned to provide early screening and detecti….
0
7
0